Nabla Bio
About:
Nabla Bio is an autoverse platform of proprietary biologically informed machine learning that co-develops antibody drugs.
Website: https://www.nabla.bio
Top Investors: Khosla Ventures, National Science Foundation, Y Combinator, Radical Ventures, Cantos
Description:
Nabla is an autoreverse platform that enables the rapid discovery of previously unattainable protein variants with supernatural qualities. Nabla Bio makes new medicines and improve nutrition by engineering novel proteins.
Total Funding Amount:
$37.4M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Cambridge, Massachusetts, United States
Founded Date:
2020-05-29
Contact Email:
http://founders(AT)nabla.bio
Founders:
Frances Anastassacos, Surge Biswas
Number of Employees:
11-50
Last Funding Date:
2024-05-14
IPO Status:
Private
© 2024 MyAiNote.com